Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1

Conditions

Ovarian Cysts 1Hemorrhage 1Gynecologic Cancer 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × FloSeal Matrix × Clear all
NCT07232927 2025-11-18

HEMOSTA-PN

Ankara University

Phase NA Completed
150 enrolled
Genitourinary

Carcinoma, Renal Cell, Hemorrhage

NCT01974193 2015-02-11

Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer

Ewha Womans University Mokdong Hospital

Phase 3 Unknown
40 enrolled
Gynecologic

Gynecologic Cancer

NCT01857466 2014-06-25

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

CHA University

Phase 3 Completed
100 enrolled
Gynecologic

Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡